Telix Pharmaceuticals Ltd. (TLX)
7.76
+0.33
(+4.44%)
USD |
NASDAQ |
Jan 16, 16:00
7.81
+0.05
(+0.64%)
Pre-Market: 20:00
Telix Pharmaceuticals Market Cap: 2.597B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inspire Medical Systems, Inc. | 2.680B |
| Immutep Ltd. | 427.94M |
| Mesoblast Ltd. | 2.233B |
| Alterity Therapeutics Ltd. | 62.53M |
| Kazia Therapeutics Ltd. | 81.17M |
Market Cap Related Metrics
| PS Ratio | 4.022 |
| Price to Book Value | 21.98 |
| Price | 7.76 |
| Earnings Yield | 0.40% |
| Operating PE Ratio | 88.40 |
| Normalized PE Ratio | 142.65 |